A results-day scorecard that rewards patience

Serco's (LSE:SRP) half-year figures, released to the London market at 07:00 on 6 August 2026, arrived with the measured cadence that has become the group's signature under Anthony Kirby, who took over as group chief executive on 1 March. Revenue for the six months to 30 June rose to £2,508m, up 4% on the £2,419m reported a year earlier. Roughly two percentage points of that growth were organic at constant currency, with the balance coming from the Mission Training & Satellite (MT&S) business acquired from Northrop Grumman. Underlying operating profit — the measure long-standing shareholders still tend to call underlying trading profit — climbed 9% at constant currency to £157m, from £146m. Statutory operating profit, which absorbs amortisation of acquired intangibles and other adjusting items, came in at £145m against £132m. The underlying margin nudged up 20 basis points to 6.2%, holding Serco at the upper end of its stated 5–6% medium-term range.

Profit inches ahead, guidance unchanged

The nub of the "beat" question is that Serco has again lifted profitability without raising its full-year guidance. Management reaffirmed the FY2026 framework: revenue of about £5.0bn on organic growth of around 3%, underlying operating profit near £300m, free cash flow of roughly £160m, and adjusted net debt of about £240m by year-end. That is consistent with the pre-close trading update of 25 June, in which the company had already flagged a robust first half and noted that MT&S was "more than offsetting" persistent US procurement delays. A first half that lands modestly ahead of the internal run-rate while the full-year outlook stays put implies either conservatism or an expectation of a softer second half; investors should weigh both readings rather than assume the former. Underlying diluted earnings per share of 10.17p, up 6%, and reported diluted EPS of 9.50p, up 10%, give the profit story a per-share dimension without flattering it.

The order-book question

Where the numbers invite closer scrutiny is order intake. Serco booked £2.5bn of new work in the first half, down markedly from an unusually strong £3.2bn a year earlier, producing a book-to-bill ratio of 100% against 134% in H1 2025. Read in isolation that looks like a slowdown; read against a bumper prior-year comparator inflated by large defence awards, it looks more like normalisation. The total order book was broadly flat at £14.6bn (£14.5bn at December 2025), while the qualified pipeline expanded to £12.8bn, described as the strongest in more than a decade. Regionally the picture was uneven: book-to-bill ran at 86% in UK & Europe and 92% in North America, but 188% in Asia Pacific on the back of contract extensions. A contract-retention rate of 95% underlines that the near-term issue is timing of new awards rather than incumbency losses.

Divisions and geographies pulling different ways

By end-market, defence has become Serco's single largest business, with revenue of £962m and organic growth of about 10%, propelled by the MT&S integration and mobilisation of Royal Navy support-vessel work. Justice and immigration — the segment that houses the politically sensitive asylum-accommodation and detention contracts — generated £784m, down from £813m, as an Asia-Pacific immigration contract rolled off. Citizen services, spanning health, transport and broader government administration, contributed £762m against £791m.

Geographically, UK & Europe remained the engine, with revenue up 8% to £1,359m, driven by immigration-related activity and defence mobilisations. North America also grew 8% to £775m, though almost all of that reflected the MT&S acquisition; underlying US momentum was still constrained by the federal procurement delays that emerged in late 2025. Asia Pacific fell 14% to £307m on the immigration exit, while the Middle East dropped 25% to £67m, with regional conflict weighing on activity. The divergence is a reminder that Serco's "international more than half of profit" narrative comes with genuine regional volatility attached.

Cash conversion softer, capital returns maintained

Free cash flow of £65m was down from £91m a year earlier, with cash conversion easing to 74% from 84% — a point management will want to explain on the call, since first-half working-capital swings are common but persistent slippage would matter for the full-year £160m target. Adjusted net debt stood at £228m, up from £206m at December 2025, leaving leverage at a comfortable 0.75x net debt to EBITDA, below the 1–2x target range. The interim dividend was raised 10% to 1.60p, and the group confirmed a £150m buyback for the year, of which £75m has been completed and a further £75m announced alongside these results. A new £400m revolving credit facility running to June 2031 underpins the balance-sheet flexibility. Taken together, the capital-allocation stance is deliberately shareholder-friendly: modest leverage, a progressive dividend and a buyback that shrinks the share count into a rising earnings base, all without stretching the balance sheet ahead of any bolt-on acquisitions the enlarged defence platform might attract.

A boardroom refresh and the concentration question

Alongside the results, Serco announced that Carol Borg, currently chief financial officer at Amadeus and formerly CFO of QinetiQ, will join as an independent non-executive director from 1 December 2026, becoming risk committee chair on 4 March 2027 as Ian El-Mokadem steps down after nine years. Her defence-sector background fits the group's tilt toward military work. That tilt sharpens an ever-present risk: Serco's fortunes are bound tightly to a handful of government customers, chiefly the UK Home Office, the US federal government and Australian agencies. Policy shifts on asylum accommodation, defence budgets or procurement pace can move revenue lines quickly, as the US delays and Asia-Pacific exit both illustrate.

What it means for the results-day verdict

On balance, Serco has delivered a solid, margin-accretive first half rather than a spectacular one. Profit and margin edged ahead of the prior year, the dividend and buyback signal confidence, and the pipeline is at a decade high — yet guidance was held, order intake normalised from an elevated base, and cash conversion softened. Whether that constitutes "beating expectations again" depends on where consensus sat going in; the profit line looks a shade better than the June steer implied, but this is evolution, not surprise. The attention now shifts to the analyst call and to how far the record pipeline converts into second-half awards. As ever, past performance is no guide to future returns, and none of the above is advice.